HealthSpot, a provider of enclosed telemedicine kiosks, unveiled the telehealth industry’s first integrated lab test with Samsung Electronics’ rapid lab testing device at NACDS Expo in Denver on Monday. Samsung’s latest medical innovation, the Samsung LABGEO PT10 is a smart, compact clinical chemistry analyzer that will quickly analyze patient blood samples while they wait with just a drop of blood from a finger stick. Pending FDA approval, both patients who visit a HealthSpot station, and their providers will get accurate results back from a variety of blood tests in as little as 7 minutes.
With the addition of Samsung’s blood analyzer, consumers will be able to get affordable and on-demand lab results in addition to access to healthcare providers, inside HealthSpot stations at convenient retail pharmacy locations. The Samsung LABGEO PT10 saves time for clinicians, improving efficiency and accuracy through automated and rapid testing in seven minutes. It also reduces wait times for consumers while requiring less blood from the patient for the analysis.
“Adding labs to HealthSpot significantly enhances our mission to transform healthcare for consumers and providers. We are transforming retail clinics into a true extension of the local medical community and widening the scope of services that can be offered via telehealth. The addition of blood analysis via Samsung’s smart point-of-care technology will allow providers to go one step further for virtual exams inside the HealthSpot station and serve patients better than ever before,” said HealthSpot CEO Steve Cashman in a statement. “We are helping consumerize healthcare-no more needles, no more wait and all at a lower cost. People like that.”
